Cargando…
Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories
BACKGROUND: High-risk human papillomavirus (HR-HPV) testing is more sensitive than cytology for the detection of cervical cancer and its precursors. However, limited and inconsistent data are available about the efficacy of the combination of these two methods for screening cervical adenocarcinoma....
Autores principales: | Xie, Fengxiang, Zhang, Liran, Zhao, Dongman, Wu, Xuefen, Wei, Mingsong, Zhang, Xuelian, Wu, Xiaohui, Fang, Hao, Xu, Xue, Yang, Meng, Qi, Debo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849166/ https://www.ncbi.nlm.nih.gov/pubmed/31711435 http://dx.doi.org/10.1186/s12879-019-4614-y |
Ejemplares similares
-
Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs
por: Zhao, Dongman, et al.
Publicado: (2020) -
Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
por: Zhang, Liran, et al.
Publicado: (2017) -
HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory
por: Jiang, Lingbo, et al.
Publicado: (2019) -
HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China
por: Zheng, Baowen, et al.
Publicado: (2017) -
High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
por: Crawford, Robin, et al.
Publicado: (2011)